LivaNova PLC (LIVN) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation.
Total Assets Chart for LivaNova PLC
LivaNova PLC (LIVN) total assets for FY2025 were USD 2.6B, a 4.0% change from FY2024. LivaNova PLC's total assets grew from USD 25.2M in 1992 to USD 2.6B in 2025 (10241.7% over 33 years). Total assets compound annual growth rate: 5-year CAGR of 1.7%, 10-year CAGR of 0.2%, 20-year CAGR of 15.3%.
Total Assets (US Dollars)
R&D as % of Revenue
Key Stats
- Market Cap
- $4.12B
- Implied Share Price
- $74.93
- Enterprise Value
- $4.09B
- Revenue (TTM)
- $1.47B
- EBITDA
- $260.14M
- Profit Margin
- 12.81%
- Trailing P/E
- 22.17
- Forward P/E
- 16.00
- Price/Book (MRQ)
- 3.23
- Price/Sales (TTM)
- 2.80
- EV/EBITDA
- 20.03
- EV/Revenue
- 2.80
- Dividend Yield
- —
- Book Value
- $24.07
- Free Cash Flow (FY2025)
- $173.20M
- Free Cash Flow Yield
- 4.21%
Snapshot as of 7th October 2026 — not point-in-time controlled, may lag the live market by a few days.